Fennec Pharmaceuticals Inc (FENC)
R&D Expense Growth
140.82%
Quarterly · Period ending:
FENC R&D Expense Growth
Latest reported140.82%period ending
Latest reported140.82%period ending
FENC Quarterly R&D Growth (QoQ) (0.00% → 140.82%)
Latest values, visible window
High-resolution chart · PNG
FENC r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 0% | |
| -100% | |
| 0% | |
| 0% |